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Abstract The Scavenger Receptor Cysteine-Rich (SRCR)
proteins are an archaic group of proteins characterized by
the presence of multiple SRCR domains. They are
membrane-bound or secreted proteins, which are generally
related to host defense systems in animals. Deleted in
Malignant Brain Tumors 1 (DMBT1) is a SRCR protein
which is secreted in mucosal fluids and involved in host de-
fense by pathogen binding by its SRCR domains. Genetic
polymorphism within DMBT1 leads to DMBT1-alleles giv-
ing rise to polypeptides with interindividually different num-
bers of SRCR domains, ranging from 8 SRCR domains
(encoded by 6 kb DMBT1 variant) to 13 SRCR domains
(encoded by the 8 kb DMBT1 variant). In the present study,
we have investigated whether reduction from 13 to 8 amino-
terminal SRCR domains leads to reduction of bacterial bind-
ing. The 6 kb variant bound ~20–45% less bacteria compared
to the 8 kb variant. These results support the hypothesis that
genetic variation in DMBT1may influence microbial defense.
Keywords SRCR domain . Genetic polymorphism .
Pathogen binding .Microbial defense
Introduction
The Scavenger Receptor Cysteine-Rich (SRCR) proteins are an
archaic group of highly conserved proteins in animals (Aruffo
et al. 1997; Freeman et al. 1990; Muller et al. 1999; Pahler et al.
1998; Resnick et al. 1994). The SRCR-superfamily is comprised
of cell membrane-anchored proteins aswell as secretory proteins.
SRCR proteins are characterized by the presence of multiple
SRCR domains. SRCR domains are approximately 110 amino
acids long and are classified into groups A and B based on the
number of conserved cysteine residues (six for groupA, eight for
group B) (Aruffo et al. 1997; Resnick et al. 1994). Generally,
SRCR proteins, e.g., the macrophage scavenger receptor, Mac2-
binding protein, CD5, CD6, and WC1, have generally been im-
plicated into host defense systems (Aruffo et al. 1997; Aruffo
et al. 1991; Elomaa et al. 1998; Freeman et al. 1990; Gough and
Gordon 2000; Holmskov et al. 1999; Ligtenberg et al. 2001;
Prakobphol et al. 2000; Tino and Wright 1999).
Deleted in Malignant Brain Tumors 1 (DMBT1) at chro-
mosome 10q25.3-q26.1 is a member of the group B SRCR
superfamily (Holmskov et al. 1997; Holmskov et al. 1999;
Ligtenberg et al. 2001; Mollenhauer et al. 1997; Prakobphol
et al. 2000). DMBT1 is composed of 13 highly homologous
SRCR domains (Aruffo et al. 1997; Hohenester et al. 1999),
separated by SRCR-interspersed domains (SIDs), two CUB
(C1r/C1s Uegf Bmp1) domains (Bork and Beckmann 1993;
Romero et al. 1997), separated by a 14th SRCR domain, and a
Zona Pellucida domain (Jovine et al. 2002; Sinowatz et al.
2001). DMBT1 is expressed in saliva (DMBT1SAG) and other
mucosal fluids along the gastro-intestinal tract, in the lungs
(DMBT1GP340), and amniotic fluid (Holmskov et al. 1997;
Holmskov et al. 1999; Ligtenberg et al. 2004; Mollenhauer
et al. 1997; Prakobphol et al. 2000; Reichhardt et al. 2014). In
saliva, the concentration of DMBT1SAG is approximately
20 μg/ml (Sonesson et al. 2011). DMBT1 plays various roles
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in innate immunity, e.g., by activating the MBL-mediated lec-
tin pathway of the complement system (Gunput 2016); it
binds to surfactant proteins A and D (Holmskov et al. 1997;
Tino andWright 1999), IgA (Ligtenberg et al. 2004), MUC5B
(Thornton et al. 2001), C-type lectin receptors DC-SIGN and
Langerin (Boks et al. 2016), influenza virus and HIV
(Hartshorn et al. 2003; Stoddard et al. 2007), the dental hard
tissue (Bikker et al. 2013), and a wide spectrum of bacteria
(Bikker et al. 2004; Bikker et al. 2002; Leito et al. 2008;
Madsen et al. 2010). In particular, the SRCR/SID region in
DMBT1 appears to play a dominant role in bacterial binding
(Bikker et al. 2004; Bikker et al. 2002; Brittan and Nobbs
2015; Kukita et al. 2013).
We have unraveled genetic polymorphism within DMBT1
(Mollenhauer et al. 1999; Mollenhauer et al. 2002b). This
results in DMBT1 alleles encoding polypeptides that have
different numbers of SRCR domains within the SRCR/SID
region, ranging from 8 to 13. This SRCR/SID region does
not include the carboxy-terminal SRCR domain, which is lo-
cated in between the CUB domains. This 14th SRCR domain
does not show bacterial-binding activity (Holmskov et al.
1997). Based on analogies to mucins, we postulate that these
polymorphisms may lead to a differential efficacy in mucosal
protection (Kohlgraf et al. 2003; Mollenhauer et al. 2001;
Mollenhauer et al. 2000; Polley et al. 2015).
In the present study, we have selected individuals homozy-
gous for either 8 or 13 SRCR domains and showed a corre-
sponding reduction of the protein size of DMBT1SAG. We
consistently observed that, compared to wild-type DMBT1
(8 kb, 13 SRCR domains in the SID/SRCR region), the short
DMBT1variant (6 kb, 8 SRCR domains in the SID/SRCR
region) displayed 30–45% reduced capacity in binding to bac-
teria in vitro.
Materials and methods
Southern blotting
Genomic DNA from healthy volunteers (ethnic background:
Caucasian) was extracted from peripheral blood leukocytes
(PBL) according to standard procedures. Collection of blood
samples and genetic analyses were approved by the ethics
committee of the University of Heidelberg. Twenty-
microgram of genomic DNAwas digested overnight with the
restriction enzyme RsaI (Roche Diagnostics; 10 U/μg DNA),
ethanol-precipitated, and resuspended in a total volume of
40 μl H2O. The digested DNAwas separated for 20–22 h on
1.2% (w/v) agarose gels at 45 V. From this point on, everything
was exactly done as described previously (Mollenhauer et al.
1999), with the exception that exclusively probe DMBT1/
sr1sid2 was used.
Bacteria
Streptococcus mutans (Ingbritt), Streptococcus gordonii
(HG222) and Escherichia coli (F7) were cultured on blood agar
plates under anaerobic conditionswith 5%CO2 at 37 °C for 24 h.
Subsequently, single colonies were cultured in Todd Hewitt me-
dium and in Luria Broth (Oxoid, Hampshire, United Kingdom)
for S. mutans, S. gordonii, and E. coli, respectively, overnight in
air/CO2 (19:1), at 37 °C. Cells were harvested and washed twice
in TTC buffer (TBS-Tween-Calcium buffer: TBS, 150 mM
NaCl, 10 mM Tris-HCl, pH 7.4; 0.01% (v/v) Tween 20 (poly-
sorbate, Merck-Schuchardt, Germany); 1 mM calcium).
Helicobacter pylori (NCTC 11637) was cultured on selective
Dent plates (Oxoid) at 37 °C for 72 h. H. pylori was harvested
by wiping off the plates and washed twice in NTC buffer
(100 mM Sodium acetate, pH 4.2, 0.01% (v/v) Tween 20, sup-
plemented with 1 mM calcium). Bacteria were diluted in buffer
to a final OD700 of 0.5, corresponding with approximately
5 × 108 cells/ml.
Collection of DMBT1SAG and determination of relative
concentration
Human parotid saliva was collected from healthy donors with
a Lashley cup, under stimulation by chewing on sugar-free
chewing gum. Collection and use of saliva was approved by
the ethics committee of the University of Heidelberg. Twenty-
five milliliters of parotid saliva was kept on ice water for
30 min, to promote the formation of a precipitate. This pre-
cipitate was collected by centrifugation at 5000xg at 4 °C for
20 min. The resulting pellet was dissolved in 2.5 ml TBS. The
pellet was approximately tenfold enriched in DMBT1SAG
(~200 μg/ml), designated as crude DMBT1SAG.
For qualitative adhesion assays with DMBT1SAG, crude
DMBT1SAG samples from saliva donors (A and B) were ti-
trated against monoclonal antibody (mAb) DMBT1h12. The
antibody recognizes a non-repetitive, non SRCR domain, pep-
tide epitope (amino acid 26–40), which is present within all
known DMBT1 variants and locates outside the region that
shows germline deletions (Fig. 2a) (Stoddard et al. 2007).
High affinity microtiter plates (Greiner-F, Polysorp, Nunc,
Kamstrup, Denmark) were coated with crude DMBT1SAG,
in coating buffer (100 mM sodium carbonate, pH 9.6) for
2 h at 37°C. This incubation and all the following steps were
carried out in a volume of 100 μl per well at room tempera-
ture, and all washes and incubations were carried out in TTC
Buffer. Plates were incubated for 1 h with 1:500 mAb
DMBT1h12. After washing, the plates were incubated at
37 °C for 1 h with a rabbit anti-mouse IgG-HRP conjugate
(dilution 1:2000 in TTC; DAKO A/S, Denmark). Subsequent
to three washes with TTC, 100 μl TMB-solution (3,3′,5,5′-
Tetramethyl-benzidine; 125 μg/ml in citrate buffer pH 4.5
with 0.05% v/v H2O2) was added, and after incubation at RT
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for 10–15 min, the reaction was stopped by the addition of
50 μl 2 M sulphuric acid per well. The absorbance was read at
405 nm on a DynatechMR7000 plate reader (Billington, UK).
The results of the ELISA were used to dilute the different
DMBT1SAG samples to obtain solutions containing compara-
ble concentrations of the uniqueDMBT1 epitope, which is not
the SRCR-epitope. For the adhesion assay, these equalized
DMBT1SAG solutions were coated onto microtiterplates.
Adhesion assays
Bacterial adhesion was examined using a microtiter
plate method based on labeling of microorganisms with
cell-permeable DNA-binding probes (Bikker et al. 2004;
Bikker et al. 2002). Microtiterplates Fluotrac 600
(Greiner, Recklinghausen, Germany) were coated with
equal amounts of crude SAG from donors A and B.
For this, the samples were dissolved in coating buffer
(100 mM sodium carbonate, pH 9.6) and diluted serial-
ly. Bovine Serum Albumin (BSA, Sigma-Aldrich,
Zwijndrecht, the Netherlands), coated from 1 to 0.01%,
was used a control. This experiment was conducted af-
ter the adhesion experiments using DMBT1SAG. After
incubation at 4 °C for 16 h, plates were washed twice
with TTC. In case of H. pylori, plates were washed
with NTC. Subsequently, 100 μl of a bacterial suspen-
sion (5 × 108 bacteria/ml) were added to each well and
incubated for 2 h at 37 °C. Plates were washed three
times with TTC, or NTC for H. pylori, using a plate
washer (Mikrotek EL 403, Winooski, VT). Bound bac-
teria were detected using 100 μl/well of 1 mM SYTO-9
solution (Molecular Probes, Leiden, The Netherlands), a
cell-permeable fluorescent DNA-binding probe. Plates
were incubated in the dark for 15 min at ambient tem-
perature and washed three times with 0.1% Tween 20.
Fluorescence was measured in a fluorescence microtiter
plate reader (Fluostar Galaxy, BMG Laboratories,
Offenburg, Germany) at 488 nm excitation and
509 nm emission wavelength. The experiments were
performed four times, in duplicate.
SDS-PAGE and western blotting
Samples were incubated at 100 °C for 10 min in sample buffer
containing 15 mM Tris-HCl, pH 6.8, 0.5% SDS, 2.5% glyc-
erol, 25 mM dithiothreitol and 0.05% bromophenol blue.
SDS-PAGE was conducted on a Pharmacia Phast System
(Pharmacia-LKB, Uppsala, Sweden) using 7.5% polyacryl-
amide gels, according to the manufacturers protocol. The ap-
proximate concentration DMBT1SAG loaded on SDS-PAGE
was 2 μg.
Western blotting was performed as described before
(Ligtenberg et al. 2001). Nitrocellulose membranes were
incubated with mAb DMBT1h12 antibodies. Bound an-
tibodies were detected with alkaline phosphatase-
conjugated to rabbit anti-mouse immunoglobulins
(DAKO, Glostrup, Denmark) using 5-bromo-4-chloro-3-
indolyl-phosphate (X-P) and nitro blue tetrazolium chlo-
ride (NBT) (Boehringer Mannheim, Germany) as
substrate.
Statistical analysis
The mean bacteria binding activity of the 6 and 8 kb variant
was compared with Mann-Whitney U tests, using IBM SPSS
Statistics for Windows version 20.0 (IBM Corp, Armonk NY.
USA). P values <0.05 were considered statistical significant.
Results
Determination of interindividual polymorphism
of DMBT1
Some years ago, we discovered genetic polymorphism within
DMBT1 (Mollenhauer et al. 2002a; Mollenhauer et al. 1999;
Mollenhauer et al. 2002b) (Fig. 1). This lead us to hypothesize
that this polymorphism results in a differential efficacy in
mucosal protection. In order to answer this hypothesis, we
first screened 200 persons for genetic DMBT1 polymorphism.
We found two persons (donors A and C) that were homozy-
gous for a small DMBT1 variant with 8 SRCR domains in the
SID/SRCR region (encoded by the 6 kb DMBT1 variant).
Furthermore, we found two persons (donors B and D) that
were homozygous for a large DMBT1 variant with 13 SRCR
domains in the SID/SRCR region (encoded by the 8 kb
DMBT1variant) (Fig. 1).
Now that DMBT1 polymorphism was found on a genetic
level, we wanted to confirm these findings on the polypeptide
level. For this, we collected DMBT1SAG from the four donors
and analyzed protein size by SDS-PAGE and subsequent
Wes t e r n ana l y s i s , u s i ng mAb DMBT1h12 fo r
immunodetection. In SDS-PAGE DMBT1SAG of donors A
and C migrated to a position corresponding with an apparent
molecular mass of approximately 255 kDa. DMBT1SAG of
donors B and D migrated in SDS-PAGE to a position corre-
sponding with an apparent molecular mass of approximately
340 kDa. These data agreed with the genetic analysis (Fig. 1),
revealing that on the one hand donors A and C express the
Bshort^ DMBT1SAG of 255 kDa, which putatively contains 8
SRCR domains in the SID/SRCR region. On the other hand,
donors B and D express the Blong^ DMBT1SAG isoform,
which putatively contains the SID/SRCR region with 13
SRCR domains (Figs. 1 and 2a).
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Fig. 1 DMBT1 polymorphism leads to different length DMBT1
polypeptides. a Schematical presentation of the exon-intron structure
within the relevant region of DMBT1 with resulting RsaI restriction
fragment sizes depicted below. Gray boxes denote restriction fragments
hybridizing with the probe DMBT1/sr1sid2. SR exons coding for
scavenger receptor cysteine-rich domains. The hypothetical
configurations within the proteins are depicted below. In the carboxy-
terminal part of the protein resulting from the deleted allele, it cannot be
discerned between a loss of either SR9, SR10, or SR11. Only one of the
possibilities is shown. Pink triangle signal peptide, blue box motif
without homology, SRCR scavenger receptor cysteine-rich domain,
CUB C1r/C1s-Uegf-Bmp1 domains, ZP zona pellucida domain. EHD
Ebnerin-homologous domain, orange ovals SRCR interspersed
domains (SIDs), TTT and STP are threonine and serine-threonine-
proline-rich domains, respectively. b Top panel Southern blot analysis
of the DMBT1 genomic configuration in four individuals (A–D)
selected from the panel. Band sizes and exons locating on the
restriction fragments are depicted at the left. Bottom panel Western blot
analysis of DMBT1SAG protein sizes in the partially purified and
concentration-adjusted saliva samples of the four probands. The
arrowhead denotes the position of the 220-kDa marker band.
DMBT1SAG was collected from saliva donors that were homozygous
for DMBT1/8 kb (donors A and C), homozygous for DMBT1/6 kb
(donors B and D). Crude DMBT1SAG from the four donors samples
were separated on 7.5% polyacrylamide gels, transferred to
nitrocellulose and immunoblotted with mAb DMBT1H12 . Lane 1
donor A, lane 2, donor B; lane 3, donor C; lane 4, donor D.
DMBT1SAG of donors A and C migrated at a position corresponding to
an apparent molecular mass of approximately 340 kDa. DMBT1SAG of
donors B and D runs at a position corresponding to approximately
255 kDa
Fig. 2 Bacterial binding is dependent on DMBT1 polymorphism. a
Domain structure of the DMBT1-variant expressed from the large
DMBT1 allele (DMBT1/8 kb, 13 SRCR domains within the SRCR/SID
region) and the small DMBT1 allele (DMBT1/6 kb, 8 SRCR domains
within the SRCR/SID region). Pink triangle leader peptide, blue box
sequence contains unique epitope for mAb DMBT1H12, red ovals
SRCR domains, orange ovals, SRCR interspersed domains (SIDs),
purple boxes C1r/C1s-Uegf-Bmp1 domains, green oval zona pellucida
domain, EHD Ebnerin-Homologous Domain. b Bacterial binding to
DMBT1/8 kb and DMBT1/6 kb (A) was semi-quantified using
S. mutans (S.m), S. gordonii (S.g.), E. coli (E.c.), and H. pylori (H.p.).
Relative to the wild typeDMBT1SAG/8 kbwe found, on amolecular base,
a decrease in bacterial binding to DMBT1SAG/6 kb for all bacteria tested.
Error bars represent the standard error of the mean (SEM), P ≤ 0.05
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DMBT1 polymorphism leads to differential bacterial
binding
To examine whether this polymorphism affects biological rel-
evant function of DMBT1SAG, we compared the bacteria-
binding properties of two different genetic variants from do-
nors A (8 kb) and B (6 kb). First, the DMBT1SAG content of
the various preparations was quantified in ELISA using
mAbDMBT1h12. Then, each sample was diluted so that the
preparations matched each other in epitope concentration, as
was verified by western analysis using mAb DMBT1h12
(Fig. 1b). The solutions subsequently were used to coat mi-
crotiter plate wells. Equal coating densities of the different
DMBT1 preparations were confirmed by ELISA.
The wells coated with DMBT1SAG were incubated with var-
ious bacterial species, including S. mutans, S. gordonii, E. coli,
and H. pylori for 1 h. After washing and addition of the
fluorogenic probe, the number of adhering cells was quantified
by fluorescence (Fig. 2). The results indicated that wells coated
with the short variant DMBT1SAG 6 kb bound, on a molar base,
significantly less bacteria, than those coated with the long-
variant DMBT1SAG 8 kb. The relative difference in binding
for the bacteria tested were 42.4% (+/−11.7) for S. mutans
(P = 0.016), 32.5% (+/−2.7) for S. gordonii (P = 0.031),
44.3% (+/−15.5) for E. coli (P = 0.029) and 35.1% (+/−16.0)
forH. pylori (P = 0.032) (Fig. 2b). No binding was observed on
the BSA coated microplates (data not shown).
Discussion
In this study, we demonstrated that genetic polymorphism,
i.e., a reduction of the tandem repeat of the SRCR domains
and SIDs of DMBT1, results in a corresponding reduction of
the protein size (Fig. 1 and 2a). In a previous study, using an
ELISA based adherence assay, was shown that DMBT1SAG
displays binding to a wide variety of bacteria. Using this assay,
we quantified bacterial binding of DMBT1 variants isolated
from donors with different genotypes. Based on the assump-
tion that a single SRCR domain contains a single bacterial
binding site, located in a putative cleft (Bikker et al. 2004;
Bikker et al. 2002; Muller et al. 1999), 8 SRCR within the
SRCR/SRCR region domains should theoretically contain
38% less binding capacity than 13 SRCR domains.
We observed that, compared to wild-type DMBT1 (8 kb,
13 SRCR domains in the SID/SRCR region), the short
DMBT1variant (6 kb, 8 SRCR domains in the SID/SRCR
region) displayed an about 30–45% reduced capacity to bind
Gram-positive and Gram–negative bacteria in vitro. This sug-
gests that genetic polymorphism of DMBT1 impairs its pro-
tective functions, as supported by complete inactivation in
DMBT1-knockout mice (Renner et al. 2007). Genetic poly-
morphism within DMBT1 has been described extensively and
appears to be exceptionally high (Mollenhauer et al. 2000;
Mollenhauer et al. 1999; Polley et al. 2015). It has also been
reported for other SRCR proteins as well, and seems to be an
overall characteristic feature of members of the SRCR super-
family. Genetic polymorphism for SRCR proteins has been
reported, e.g., for human CD5 (Padilla et al. 2000), human
CD163 sponge Aggregation Receptor (Muller et al. 1999;
Pancer 2000), and sheep T19 (Walker et al. 1994). Genetic
polymorphism ofDMBT1was suggested to be linked to func-
tionality, i.e., bacterial binding and hydroxyapatite binding of
the polypeptide of DMBT1SAG (Bikker et al. 2013; Bikker
et al. 2002). Copy number variants that bound strongly to
S. mutans and less to hydroxyapatite seemed to be increased
in agricultural populations compared to hunter-gatherer pop-
ulations and ancient hominins (Polley et al. 2015). As
S. mutans is the causative agent in dental caries; it was spec-
ulated that some kind of selection for caries resistance had
occurred in agricultural populations. We show that deletion
of the SRCR domains not only affects binding to S. mutans,
but also to other bacteria. Selective pressure from other bac-
terial infections, which occur more frequently in agricultural
populations, may have favored the selection of strong binding
copy number variants.
It has to be noted that in this study crude preparations of
DMBT1SAG were used for bacterial adhesion analysis.
Although, it cannot be excluded that a variety of proteins
such as amylase, proline rich proteins, and s-IgAmay have co-
precipitated with DMBT1SAG; it appears that crude
DMBT1SAG shows representative bacteria binding character-
istics. In line with earlier studies with purified DMBT1SAG
and recombinant DMBT1, crude DMBT1SAG preparations
show comparable bacteria binding characteristics (Bikker
et al. 2004; Bikker et al. 2002; End et al. 2009; End et al.
2005; Leito et al. 2008; Ligtenberg et al. 2004; Ligtenberg
et al. 2001). And, as DMBT1SAG is obtained directly from
the parotid gland, the presence of bacteria-binding salivary
mucins (MUC7) can be excluded (Veerman et al. 1996).
The present data suggest that the SRCR/SID region defines
a complex multi-allele system that represents a possible basis
for the variability in human susceptibility to infection as sug-
gested in earlier papers (Mollenhauer et al. 2002a; von
Deimling et al. 2000).
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